Indian pharma sector to grow 9-11% in FY26: From Lupin to Max Healthcare—Top 5 stock picks by Motilal Oswal for 2025 | Stock Market News

The Indian pharma industry is likely to grow at 9-11 per cent in FY26, led by…

Stock market today: Trade setup for Nifty50, Sensex for today – five stocks to buy or sell on Wednesday | Stock Market News

Indian stock market: The frontline indices—the Sensex and the Nifty 50—marginally lower on Tuesday, July 23.…

ChrysCapital to bet big on branded healthcare in India, says MD Raghav Ramdev

Mumbai: Private-equity firm ChrysCapital, which invested $100 million in eyecare chain Centre For Sight on 14…

IPCA Laboratories Q3 FY24 Results Live : profit rise by 66.8% YOY

IPCA Laboratories declared their Q3 FY24 results on 14 Feb, 2024. The topline increased by 32.79%…

Q3 Results Today: M&M, NMDC, Muthoot Finance, ABFRL to post earnings on Feb 14

Q3 Results Today: Mahindra & Mahindra, NMDC, Muthoot Finance, Natco Pharma, Indiabulls Housing Finance, and Shriram…

IPCA Laboratories Q2 FY24 results: profit rise by 0.81% YOY

IPCA Laboratories, a leading pharmaceutical company, announced its financial results for the second quarter of FY24…

Ipca Labs API plant in Ratlam gets 11 U.S. FDA observations

Drugmaker Ipca Laboratories’ active pharmaceutical ingredients (API) manufacturing facility in Ratlam, Madhya Pradesh, has been issued…

Why do analysts see 40% upside potential in this pharma stock in 6 months?

with a market valuation of 21,667.40 Cr, IPCA Laboratories is a Large-cap company engaged in Pharmaceutical…

Pain likely to continue in Ipca labs

Ipca Laboratories Ltd shares are down nearly 3% since the December quarter (Q3FY22) results were announced…